Fundamental Data for BCR

BARD C R I(NYSE:BCR)

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

# Employees: 11000

Address: 730 Central Avenue,Murray Hill,NJ,USA

Phone: 908-277-8000

Fax: 908-277-8078

Website: www.crbard.com

Email: investorrelations.crbard.com

Sector: Medical

Industry: MED/DENTAL-SUPP

Executive Officers

Timothy M. Ring (Chmn.; C.E.O.; Dir.)

John H. Weiland (Presi.; C.O.O.; Dir.)

John A. Deford (Sr. V.P.; Science; Technology and Clinical Affairs)

Todd C. Schermerhorn (Sr. V.P.; C.F.O.)

James L. Natale (Presi.; Sr. V.P.; Corporate Healthcare Services,)

Dividend

Ex-Dividend Date: 10/22/2009

Annual Dividend: $0.68

Current Dividend Yield: $0.84

Dividend Paid (3 months): $0.17

Indicated Dividend: $0.14

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 1/28/2010

Mean EPS (Next Qtr): $1.34

Mean EPS (Year): $5.05

Mean Estimate(Long Term): $13.67

P/E Ratio(Based on EPS estimate): 15.990

Number of Estimates: 18

Shares Performance

Period	BCR	Compare to S&P
YTD	-4.20 %	-20.72 %
4 Weeks	5.19 %	4.05 %
12 Weeks	0.51 %	-5.24 %

Shares Information

Analyst Coverage: Y

Avg Volume: 796775

Shares Outstanding: 97M

Market Cap: $7.88B

52 Week High: $88.41

52 Week Low: $70.39

P/E Ratio: 16.470

PEG Ratio: 1.170

Split: On 6/1/2004 BCR split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 6.50 %

EPS Growth in Last Year: 19.09 %

Sales Growth in Last Quarter: 1.99 %

Sales Growth in Last Quarter: 3.27 %

Financials

Qtr Book Value: $3.64

Cash Flow/Share: $14.64

Change in Payout Ratio: -0.020

Price/Sales: 3.160